Commodore Capital LP Acumen Pharmaceuticals, Inc. Transaction History

Commodore Capital LP

  • $1.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$3.75 - $6.65 $368,681 - $653,794
-98,315 Reduced 19.73%
400,000 $1.62 Million
Q4 2022

Feb 14, 2023
SELL
$4.81 - $10.17 $2.89 Million - $6.12 Million
-601,685 Reduced 54.7%
498,315 $2.69 Million
Q3 2022

Nov 14, 2022
BUY
$4.44 - $10.48 $4.88 Million - $11.5 Million
1,100,000 New
1,100,000 $11 Million

Others Institutions Holding ABOS

# of Institutions
78
Shares Held
41.8M
Call Options Held
57.7K
Put Options Held
749K
View Full List

About Acumen Pharmaceuticals, Inc.

ABOS Quotes by TradingView
  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $72.5M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Commodore Capital LP Portfolio

Follow Commodore Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email